Manufacturers Life Insurance Company, The Cti Biopharma Corp Transaction History

Manufacturers Life Insurance Company, The

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.08 - $9.1 $160,662 - $358,339	-39,378 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$4.45 - $6.17 $7,351 - $10,192	1,652 Added 4.38%	39,378 $236,000
Q4 2022 Feb 13, 2023	BUY	$4.45 - $6.17 $7,351 - $10,192	1,652 Added 4.38%	39,378 $236,000
Q3 2022 Aug 11, 2023	SELL	$5.36 - $7.43 $4,759 - $6,597	-888 Reduced 2.3%	37,726 $219,000
Q3 2022 Nov 03, 2022	SELL	$5.36 - $7.43 $4,759 - $6,597	-888 Reduced 2.3%	37,726 $220,000
Q2 2022 Aug 11, 2023	SELL	$3.55 - $6.27 $2,712 - $4,790	-764 Reduced 1.94%	38,614 $230,000
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $137,079 - $242,109	38,614 New	38,614 $231,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $81,595 - $248,580	-47,439 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.81 - $5.26 $170,668 - $235,621	44,795 Added 1694.21%	47,439 $236,000
Q4 2017 Feb 08, 2018	BUY	$2.47 - $3.34 $5,794 - $7,835	2,346 Added 787.25%	2,644 $7,000
Q3 2017 Nov 14, 2017	BUY	$3.12 - $3.65 $929 - $1,087	298	298 $1,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.